Company intelligence / Profile preview

Mapmygenome

Hyderabad, Telangana, Indiamapmygenome.in ↗

Ownership: Private
Employees: ~75
Development stage: Commercial

Overview

Mapmygenome offers a suite of at-home DNA tests and advanced genomic diagnostics covering health risks, pharmacogenomics, ancestry, cancer panels, prenatal testing, and microbiome analysis. The company has expanded globally through the acquisition of Microbiome Insights in 2025. It operates accredited labs in India and Canada. No clinical trial results as it is a diagnostics company.

Therapeutic areas: OtherRare DiseasesOncology
Modalities: Diagnostic testGenomic testPharmacogenomicsMicrobiome sequencingNon-pharmacological therapy
Industry: Molecular Diagnostics

Partnerships

Academic collaborations via Microbiome Insights' CRO business supporting academic/clinical research globally. No major pharma partnerships disclosed.

Beyond the preview

Go deeper on Mapmygenome.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mapmygenome.

Explore the full profile